Viz.ai Receives First De Novo Approval by the FDA for AI Algorithm for...
New artificial intelligence algorithm for earlier detection and management of hypertrophic cardiomyopathy SAN FRANCISCO, CA – August 15, 2023 -...
Aug 15, 2023
Press & News
Explore our News & Press
Viz.ai Appoints Hypertrophic Cardiomyopathy Medical Advisory Board to Advance Innovation
Leading experts to shape the future of Viz.ai’s HCM strategy and platform SAN FRANCISCO - May 4, 2023 - Viz.ai,...
May 04, 2023
Viz.ai Announces Agreement with Bristol Myers Squibb to Enable Earlier Detection and Management...
Viz.ai has submitted a de novo classification request to the FDA for a new AI algorithm intended to identify and...
Mar 02, 2023
Viz.ai Launches AI-Powered Viz™ Cardio Suite
Comprehensive solution tailored for cardiovascular care teams to improve care pathways and grow referrals CHICAGO & SAN FRANCISCO--(BUSINESS WIRE)--AMERICAN HEART...
Nov 04, 2022
Viz.ai Partners with Us2.ai to Deliver AI-Enabled Echocardiography Decision Support with the Viz™...
Partnership delivers critical insights to cardiac care teams for faster patient triage and care. SAN FRANCISCO--(BUSINESS WIRE)--Viz.ai, the leader in...
Nov 02, 2022